Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Increased Prothrombotic State in Patients with Advancing HIV Disease.

Willem M. Lijfering, MD, Herman G. Sprenger, MD, Rita R. Georg, Piet A. van der Meulen, Jan van der Meer, MD, PhD

Blood (2007) 110 (11): 2274.

https://doi.org/10.1182/blood.V110.11.2274.2274

Published: 2007

Journal Articles

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Nienke Folkeringa, MD, Jan Leendert P. Brouwer, MD, Nic J.G.M Veeger, MSc, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1484.

https://doi.org/10.1182/blood.V108.11.1484.1484

Published: 2006

Journal Articles

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1486.

https://doi.org/10.1182/blood.V108.11.1486.1486

Published: 2006

Journal Articles

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

Nienke Folkeringa, MD, Jan-Leendert P. Brouwer, MD, Fleurisca J. Korteweg, MD, Nic J.G.M Veeger, MSc, Jan Jaap H.M. Erwich, MD PhD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1485.

https://doi.org/10.1182/blood.V108.11.1485.1485

Published: 2006

Journal Articles

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 273.

https://doi.org/10.1182/blood.V108.11.273.273

Published: 2006

Journal Articles

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

Nic J.G.M. Veeger, MSc, Margriet Piersma-Wichers, MD, Jan van der Meer, MD, PhD

Blood (2006) 108 (11): 889.

https://doi.org/10.1182/blood.V108.11.889.889

Published: 2006

Journal Articles

Hereditary Protein S Type III Deficiency Is Not a Risk Factor for Venous and Arterial Thrombosis, in Contrast to Protein S Deficiency Type I. Results from a Family Cohort Study To Assess the Clinical Impact of a Laboratory Based Classification.

Jan-Leendert P. Brouwer, MD, Nic J.G.M. Veeger, MSc, Wim van der Schaaf, Ing, Hanneke C. Kluin-Nelemans, MD PhD, Jan van der Meer, MD PhD

Blood (2004) 104 (11): 1056.

https://doi.org/10.1182/blood.V104.11.1056.1056

Published: 2004

NARROW

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Increased Prothrombotic State in Patients with Advancing HIV Disease.

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

Hereditary Protein S Type III Deficiency Is Not a Risk Factor for Venous and Arterial Thrombosis, in Contrast to Protein S Deficiency Type I. Results from a Family Cohort Study To Assess the Clinical Impact of a Laboratory Based Classification.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only